Voxilaprevir
Voxilaprevir is a small molecule protease inhibitor targeting the HCV NS3/4A protein. It is utilized in antiviral research to study HCV replication and infection mechanisms, both in cell-based assays and in preclinical animal models.
Product Specifications
CAS Number
1535212-07-7
Product Name Alternative
Voxilaprevir, Inhibitor, HCV, HCV Protease, HCVProtease, GS9857, GS-9857, GS 9857, infection, inhibit, pangenotypic, antiviral, direct-acting antiviral, DAA
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.00% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:2 mg/mL (2.3 mM) ; DMSO:22.5 mg/mL (25.89 mM)
Smiles
[H][C@]12CN ([C@@H] ([C@@H]1CC) C (=O) N[C@@]1 (C[C@H]1C (F) F) C (=O) NS (=O) (=O) C1 (C) CC1) C (=O) [C@@H] (NC (=O) O[C@@H]1C[C@H]1CCCCC (F) (F) c1nc3ccc (OC) cc3nc1O2) C (C) (C) C
Molecular Formula
C40H52F4N6O9S
Molecular Weight
868.93
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
